LENSAR Inc (NAS:LNSR)
$ 7.53 -0.16 (-2.08%) Market Cap: 87.46 Mil Enterprise Value: 71.27 Mil PE Ratio: 0 PB Ratio: 3.85 GF Score: 53/100

LENSAR Inc at Piper Sandler Healthcare Conference Transcript

Nov 30, 2022 / 07:50PM GMT
Release Date Price: $3.31 (-0.30%)
Phil Dantoin
Piper Sandler & Co. - Analyst

All right, everybody. I guess some interesting time here. We'll get started here. My name is Phil Dantoin. I work here on Piper's MedTech team. I'm very excited to have LENSAR here with us today. And here from the company is Chief Executive Officer, Nick Curtis. So with that, I'll pass it over to Nick. Very (inaudible).

Nick Curtis
LENSAR Inc. - CEO

Yeah. First off, I'd like to thank the Piper team as well as Matt for inviting LENSAR to present today. As Phil said, I'm Nick Curtis. I am the CEO of LENSAR. I appreciate you taking the time to listen to the presentation, and I look forward to telling you a little bit about LENSAR and what we're doing in this market, the markets that we serve. Please review the information on the slide two regarding any forward-looking statements that I make in the presentation. Our SEC filings can be accessed on our website.

LENSAR is a technology leader. We're in the premium femtosecond laser-assisted cataract surgery market. We've got a surgeon centric culture, and we're

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot